Jennison Associates’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.4M | Sell |
2,946,103
-1,024,086
| -26% | -$18.5M | 0.03% | 209 |
|
|
2025
Q1 | $81.3M | Sell |
3,970,189
-28,352
| -0.7% | -$580K | 0.06% | 148 |
|
|
2024
Q4 | $103M | Buy |
3,998,541
+2,978,263
| +292% | +$76.5M | 0.06% | 140 |
|
|
2024
Q3 | $16.9M | Buy |
1,020,278
+83,115
| +9% | +$1.38M | 0.01% | 359 |
|
|
2024
Q2 | $18M | Buy |
937,163
+6,312
| +0.7% | +$121K | 0.01% | 335 |
|
|
2024
Q1 | $22M | Buy |
+930,851
| New | +$22M | 0.01% | 333 |
|